Relay Therapeutics Inc.

NASDAQ: RLAY · Real-Time Price · USD
3.54
0.15 (4.42%)
At close: Aug 15, 2025, 3:59 PM
3.54
0.14%
After-hours: Aug 15, 2025, 04:10 PM EDT

Relay Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
10.01M 25.55M 1.38M 3.03M
Cost of Revenue
5.46M 5.27M 4.13M 3.92M
Gross Profit
-305.43M 25.55M -241.62M -166.36M
Operating Income
-372.47M -373M -299.27M -364.7M
Interest Income
34.75M 31.05M 8.79M 830K
Pretax Income
-337.71M -341.97M -290.51M -363.87M
Net Income
-337.71M -341.97M -290.51M -363.87M
Selling & General & Admin
76.59M 74.95M 65.98M 57.39M
Research & Development
319.09M 330.02M 246.35M 172.65M
Other Expenses
-328.65M -6.42M -254.68M -31.7M
Operating Expenses
67.03M 398.55M 57.65M 198.34M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
382.48M 398.55M 300.66M 367.73M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
142.87M 122.58M 112.23M 95.14M
Shares Outstanding (Diluted)
142.87M 122.58M 112.23M 95.14M
EPS (Basic)
-2.36 -2.79 -2.59 -3.82
EPS (Diluted)
-2.36 -2.79 -2.59 -3.82
EBITDA
-380.21M -374.15M -306.82M -222.18M
EBIT
-385.67M -379.42M -310.95M -227.01M
Depreciation & Amortization
5.46M 5.27M 4.13M 3.92M